Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Amicus Therapeutics (FOLD)

14.21 -0.43 (-2.94%)

04-20 16:00

Open:

14.47

Pre. Close:

14.64

High:

14.82

Low:

14.16

Volume:

1,606,983

Market Cap:

2671M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

14.835 - 14.916

14.916 - 14.983

Low:

13.967 - 14.066

14.066 - 14.149

Close:

14.061 - 14.212

14.212 - 14.337

Technical analysis  (as of: 2018-04-20 4:29:52 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 17.85     One year: 20.85

Support:

Support1: 13.56    Support2: 12.50

Resistance:

Resistance1: 15.28    Resistance2: 17.85

Pivot:

14.14

Moving Averages:

MA(5): 14.55     MA(20): 14.24

MA(100): 14.63     MA(250): 12.96

MACD:

MACD(12,26): -0.02     Signal(12,26,9): -0.10

%K %D:

%K(14,3): 75.14     %D(3): 77.29

RSI:

RSI(14): 47.57

52-Week:

High: 17.4  Low: 6.41  Change(%): 90.7

Average Vol(K):

3-Month: 309130  10-Days 191479

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
FOLD has closed below upper band by 47.1%. Bollinger Bands are 3.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-04-15T00:25:16-04:00
Portfolio Review: Continued Market Outperformance In Q1 2018

2018-03-19T15:44:47-04:00
Protalix: A Definite Sell - No Prize For The Fourth Runner Up

2018-03-16T15:12:03-04:00
Amicus Therapeutics (FOLD) Presents At Barclays Global Healthcare Conference 2018 - Slideshow

2018-03-09T16:24:55-05:00
Daily Insider Ratings Round Up 3/7/18: FOLD, ATT, CHN, EPD, GTE, CLR

2018-03-07T18:35:48-05:00
Daily Insider Ratings Roundup For March 6, 2018: FOLD, RDUS, BW, AXDX, TMUS, GKOS, And BOMN

2018-03-01T12:05:10-05:00
ROTY Volume 1 Edition 83: Thank You For Your Patience - Launch Day Has Arrived!

2018-02-28T12:00:51-05:00
Amicus Therapeutics' (FOLD) CEO John Crowley on Q4 2017 Results - Earnings Call Transcript

2018-02-28T08:33:35-05:00
Amicus Therapeutics, Inc. 2017 Q4 - Results - Earnings Call Slides

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

186.89

Shares Float (M)

184.79

% Held by Insiders

1.10

% Held by Institutions

Shares Short (K)

27988

Shares Short Prior Month (K)

29490

Stock Financials

EPS

-1.550

EPS Est. Current Year

-1.320

EPS Est. Next Year

-1.020

EPS Est. Next Quarter

-0.290

Forward EPS

-0.830

Book Value (p.s.)

7.750

PEG Ratio

-0.06

Profit Margin

Operating Margin

-548.01

Return on Assets (ttm)

-34.1

Return on Equity (ttm)

-79.7

Qtrly Rev. Growth

420.3

Gross Profit (p.s.)

0.099

Sales Per Share

EBITDA (p.s.)

-1.948

Qtrly Earnings Growth

Operating Cash Flow (M)

-215.48

Levered Free Cash Flow (M)

-179.73

atoplab.com

Valuation

P/E

-9.17

P/E Growth Ratio

-0.03

P/BV

1.83

P/S

11065445376.00

P/CF

-12.32

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.